• español
    • English
    • português
  • English 
    • español
    • English
    • português
  • Login
Search 
  •   Home
  • Productos de Investigación - Creación
  • Search
  •   Home
  • Productos de Investigación - Creación
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.
JavaScript esta deshabilitado en su navegador. Algunas características de este sitio no podrán funcionar o visualizarse correctamente sin JavaScript.
RecursosRecursos de apoyo¿Cómo publicar?

Browse

All of ExpeditioCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Discover

AuthorMisra, Anoop (11)Vaishya, Raju (8)Bao, Linlin (7)Liu, Yang (7)Chen, Lei (6)Deng, Wei (6)Iyengar, Karthikeyan (6)Liu, Jiangning (6)Qin, Chuan (6)Gupta, Ritesh (5)... View MoreSubject
Coronavirus (2305)
COVID-19 (2298)SARS-CoV-2 (2294)Síndrome respiratorio agudo grave (2293)Pandemic (143)Covid-19 (59)Mortality (35)ACE2 (34)Vaccine (34)Inflammation (33)... View MoreHas File(s)Yes (1790)No (515)
Estadísticas GTMVer Estadísticas GTM

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 2305

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies 

Sharma, Atul; Tiwari, Swapnil; Kanti Deb, Manas; Marty, Jean Louis
The emergence and rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a potentially fatal disease, is swiftly leading to public health crises ...
Thumbnail

The role of biomarkers in diagnosis of COVID-19 – A systematic review 

Kermali, Muhammed; Kaur Khalsa, Raveena; Pillai, Kiran; Ismail, Zahra; Harky, Amer
Aims: As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries and affected over three million confirmed people. We review different biomarkers to evaluate if they are able to predict ...
Thumbnail

Efficacy and safety of integrated traditional chinese and western medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta- analysis 

Liu, Ming; Gao, Ya; Yuan, Yuan; Yang, Kelu; Shi, Shuzhen; Zhang, Junhua; Tian, Jinhui
Corona virus disease (COVID-19) has now spread to all parts of the world and almost all countries are battling against it. This study aimed to assess the efficacy and safety of Integrated Traditional Chinese and ...
Thumbnail

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 

Zhou, Yadi; Hou, Yuan; Shen, Jiayu; Huang, Yin; Martin, William; Cheng, Feixiong
Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, ...
Thumbnail

Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico) 

Remes-Troche, Jose María; Ramos-de-la-Medina, Antonio; Manríquez Reyes, Marisol; Martínez-Pérez-Maldonado, Laura; Lagunes Lara, Elizabeth; Solís-González, María Antonieta
Since it first appeared, COVID-19 has been a highly contagious disease. The virus spread rapidly across the planet, and by early May 2020, it had infected more than 4 million people in 187 countries. Although respiratory ...
Thumbnail

SARS-CoV-2 pandemic lockdown: Effects on air quality in the industrialized Gujarat state of India 

Selvam, S.; Muthukumar, P.; Venkatramanan, S.; Roy, P.D.; Manikanda Bharath, K.; Jesuraja, K.
Two weeks after the world health organization described the novel coronavirus (SARS-CoV-2) outbreak as pandemic, the Indian government implemented lockdown of industrial activities and traffic flows across the entire nation ...
Thumbnail

Vaccination strategies to combat novel corona virus SARS-CoV-2 

Pandey, Satish Chandra; Pande, Veni; Sati, Diksha; Upreti, Shobha; Samant, Mukesh
The 2019-novel coronavirus disease (COVID-19) is caused by SARS-CoV-2 is transmitted from human to human has recently reported in China. Now COVID-19 has been spread all over the world and declared epidemics by WHO. It ...
Thumbnail

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings 

Williams, Phoebe C.M.; Howard-Jones, Annaleise R.; Hsu, Peter; Palasanthiran, Pamela; Gray, Paul E.; McMullan, Brendan J.; Britton, Philip N.; Bartlett, Adam W.
As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging with regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. Overall, children appear to be less ...
Thumbnail

Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease 

Cashman, Daniel P.
There currently is no specific antiviral drug or a vaccine for SARS-CoV-2/COVID-19 infections; now exceeding 10,300,000 infections worldwide. In the absence of animal models to test drugs, we need to find molecular ...
Thumbnail

SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons 

Wellinghausen, Nele; Plonné, Dietmar; Voss, Meike; Ivanova, Ralitsa; Frodl, Reinhard; Deininger, Susanne
Commercially available immunoassays have been developed for sensitive and specific detection of antibodies against SARS-CoV-2. While a fast and reliable IgG response has been reported for samples from hospitalized COVID-19 ...
  • 1
  • 2
  • 3
  • 4
  • . . .
  • 231

Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas

 

 


Carrera 4 # 22-61 Teléfono: (+57 1) 242 7030 - 018000111022 Fax: (+57 1) 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad.

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

 

Términos y condiciones | Políticas